NASDAQ:RNXT

Renovorx Stock Earnings Reports

etoro logo Buy RNXT
*Your capital is at risk
$0.91
-0.0098 (-1.07%)
At Close: Jun 22, 2026

RenovoRx Earnings Calls

Mar 31, 2026
Release date May 14, 2026
EPS estimate -$0.0800
EPS actual -$0.0800
Revenue estimate 469.5K
Revenue actual 563K
Revenue Surprise 19.91%
Dec 31, 2025
Release date Mar 30, 2026
EPS estimate -$0.0800
EPS actual -$0.0800
Revenue estimate 419.7K
Revenue actual 238K
Revenue Surprise -43.29%
Sep 30, 2025
Release date Nov 13, 2025
EPS estimate -$0.0800
EPS actual -$0.0800
Revenue estimate 405.4K
Revenue actual 266K
Revenue Surprise -34.39%
Jun 30, 2025
Release date Aug 14, 2025
EPS estimate -$0.0800
EPS actual -$0.0800
Revenue estimate 304K
Revenue actual 422K
Revenue Surprise 38.82%

Last 4 Quarters for RenovoRx

Below you can see how RNXT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Jun 30, 2025
Release date Aug 14, 2025
Price on release $1.24
EPS estimate -$0.0800
EPS actual -$0.0800
Date Price
Aug 08, 2025 $1.14
Aug 11, 2025 $1.12
Aug 12, 2025 $1.10
Aug 13, 2025 $1.22
Aug 14, 2025 $1.24
Aug 15, 2025 $0.96
Aug 18, 2025 $0.94
Aug 19, 2025 $0.92
Aug 20, 2025 $0.87
4 days before 8.77%
4 days after -29.84%
On release day -22.94%
Change in period -23.68%
Sep 30, 2025
Release date Nov 13, 2025
Price on release $0.97
EPS estimate -$0.0800
EPS actual -$0.0800
Date Price
Nov 07, 2025 $0.96
Nov 10, 2025 $1.00
Nov 11, 2025 $1.07
Nov 12, 2025 $1.00
Nov 13, 2025 $0.97
Nov 14, 2025 $0.750
Nov 17, 2025 $0.80
Nov 18, 2025 $0.782
Nov 19, 2025 $0.733
4 days before 1.34%
4 days after -24.83%
On release day -23.03%
Change in period -23.82%
Dec 31, 2025
Release date Mar 30, 2026
Price on release $1.07
EPS estimate -$0.0800
EPS actual -$0.0800
Date Price
Mar 24, 2026 $1.08
Mar 25, 2026 $1.10
Mar 26, 2026 $1.16
Mar 27, 2026 $1.13
Mar 30, 2026 $1.07
Mar 31, 2026 $1.01
Apr 01, 2026 $0.97
Apr 02, 2026 $0.98
Apr 06, 2026 $0.93
4 days before -0.93%
4 days after -12.91%
On release day -5.61%
Change in period -13.71%
Mar 31, 2026
Release date May 14, 2026
Price on release $0.86
EPS estimate -$0.0800
EPS actual -$0.0800
Date Price
May 08, 2026 $0.86
May 11, 2026 $0.85
May 12, 2026 $0.87
May 13, 2026 $0.85
May 14, 2026 $0.86
May 15, 2026 $0.82
May 18, 2026 $0.783
May 19, 2026 $0.81
May 20, 2026 $0.81
4 days before -1.00%
4 days after -5.25%
On release day -4.09%
Change in period -6.19%

RenovoRx Earnings Call Transcript Summary of Q1 2026

RenovoRx reported its strongest quarter to date with Q1 2026 revenue of $563k, a 136% sequential increase and representing ~51% of 2025 revenue. Management attributes the growth to deliberate commercial execution and rapid expansion of active commercial cancer centers (from 8 at year-end 2025 to 16 as of May 2026) with a pipeline of 32 additional centers. The company reiterated full-year 2026 revenue guidance of $3.0–$4.0 million and expects Q2 revenue to exceed Q1. Gross margin was high (85.1%) in Q1; R&D was $1.2M and SG&A was $2.7M. RenovoRx closed an oversubscribed private placement in March raising ~$10M (total cash ~$12.4M as of March 31, 2026), which management says provides runway into H2 2027. The Phase 3 TIGeR-PaC trial is near enrollment completion (106 of 114 randomized as of May 14, 2026) with final data expected mid–late 2027; conversion of trial sites to commercial centers is expected to drive further revenue in H2 2026. Management emphasized physician-driven repeat orders, favorable toxicity profile versus systemic chemo, modest near-term R&D needs for device optimization, and a capital-efficient strategy including investigator-initiated and registry studies to broaden use cases.

RenovoRx Earnings History

Earnings Calendar

FAQ

When is the earnings report for RNXT?
RenovoRx, Inc. (RNXT) has scheduled its earnings report for Aug 13, 2026 after the markets close.

What is the RNXT price-to-earnings (P/E) ratio?
RNXT P/E ratio as of Jun 22, 2026 (TTM) is -2.85.

What is the RNXT EPS forecast?
The forecasted EPS (Earnings Per Share) for RenovoRx, Inc. (RNXT) for the first fiscal quarter 2026 is -$0.0800.

What are RenovoRx, Inc.'s retained earnings?
On its balance sheet, RenovoRx, Inc. reported retained earnings of $563.00 thousand for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE